Autologous erythrocyte-derived MPs carrying methotrexate for peritoneal perfusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous erythrocyte-derived MPs carrying methotrexate for peritoneal perfusion, covering 2017-07-26 to 2017-07-26. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites [Phase 1, Phase 2]